Angiotensin Converting Enzyme (ACE) inhibitors in renal transplant recipients with left ventricular hypertrophy

Not Applicable

Completed

• Conditions: eft ventricular hypertrophy assessed by echocardiography in non diabetic chronic kidney disease patients receiving renal transplant; Circulatory System; left ventricular hypertrophy

• Registration Number: ISRCTN94487168
• Lead Sponsor: Azienda Ospedaliera Universitaria S.Martino (Italy)

Brief Summary

2007 Results article in https://pubmed.ncbi.nlm.nih.gov/17591533

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-12-31
• Study Start: 2007-03-29
• Last Update Posted: 7 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

Non diabetic renal transplant recipients with persisting LVH following successful renal transplant

Exclusion Criteria

1. Subjects receiving second or dual transplant
2. Subjects with unstable renal graft function
3. Proteinuria > 1 g/ 24 hr
4. Congestive heart failure
5. Hemodinamically significant artery stenosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified